DNA

Ginkgo Bioworks Holdings Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth↑ 8/10
  • Momentum↓ 4/10
Ginkgo Bioworks Holdings sales and earnings growth
DNA Growth
Good
  • Revenue Y/Y↓ -17.13%
  • EPS Y/Y↑ 52.02%
  • FCF Y/Y↑ 51.43%
Ginkgo Bioworks Holdings gross and profit margin trends
DNA Profitability
Low
  • Gross margin ↑ 72.70%
  • EPS margin↓ -188.00%
  • ROIC↓ -27.60%
Ginkgo Bioworks Holdings net debt vs free cash flow
DNA Risk
Great
  • Debt / Equity↓ 0.8
  • Debt / FCF↓ 1.7
  • Interest coverage↓ -3616.7

Ginkgo Bioworks Holdings stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗